M1 Kliniken : Interim Report 2023 (1.4 MiB)

Jan-Jun 2023

Jan-Jun 2022

Sales

150,793

138,668

EBIT

7,279

4,472

30.06.2023

31.12.2022

Assets

Short-term assets

115,289

107,307

Long-term assets

87,943

89,718

Total assets

203,232

197,025

Liabilities

Short-term liabilities

42,193

37,466

Long-term liabilities

14,688

16,508

Equity

146,351

143,051

Total liabilities and equity

203,232

197,025

Class of shares

Bearer shares

Number of shares

19,643,403

WKN / ISIN

A0STSQ / DE000A0STSQ8

Ticker symbol

M12

Trading shares

Frankfurt, Xetra, Düsseldorf, Stuttgart, Berlin,

Hannover, Hamburg, München, Tradegate

Market segment

Open Market

Designated Sponsor, Listing Partner

mwb fairtrade Wertpapierhandelsbank AG

Coverage

Bankhaus Metzler, First Berlin,

M.M.Warburg & Co.

EUR 156,8 mn

Market capitalization

(as of 30.06.2023 - Xetra,

prev. year EUR 102,1 mn)

01

02

03

04

05

06

07

08

09

10

11

12

01

02

03

04

05

06

07

1.

Company Profile

06

2.

Letter to the Shareholders

06

3.

Group Interim Management Report

10

3.1

Economic environment

10

3.2

Economic situation

13

3.3

Outlook

16

4.

Group Interim Financial Statement

19

4.1

Group Balance Sheet - Assets

20

4.2

Group Balance Sheet - Liabilities

21

4.3

Group Profit And Loss Statement

22

4.4

Consolidated Cash Flow Statement

23

4.5

Consolidated Equity Change Account

24

5.

Condended Notes

25

5.1

General Information

26

5.2

Basis Of Consolidation

26

5.3

Selected Information from the

26

Consolidated Balance Sheet

5.4

Dividends

27

5.5

Contingent Liabilities and other

27

Financial Obligations

5.6

Significant Events after 30 June 2023

27

6.

Further Information

28

6.1

Sources

28

6.2

Glossary

28

6.3

Imprint

29